alexa Schnyder Corneal Dystrophy- A Window To Insights On Cholesterol, Vitamin K And Parkinson?s Disease? | 20798
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Clinical & Experimental Ophthalmology

Jayne S. Weiss
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
Schnyder crystalline corneal dystrophy (SCD), first described in 1924, is an autosomal dominant inherited disease with corneal clouding resulting from abnormal cholesterol deposition in the front of the eye, the cornea. In the late 1980?s, I discovered four large pedigrees of Swede Finn individuals with SCD. At that time, there were less than 100 articles on the disease in the peer reviewed literature. In 1992, I published the clinical findings in 18 affected members of these families I had examined which was the largest number of affected patients ever described in one publication at that time. One new finding was that although the disease name was Schnyder crystalline corneal dystrophy, only 50% of affected individuals actually had corneal crystals. Both affected and unaffected members of SCD pedigrees may have elevated blood cholesterol making it difficult to determine if high circulating cholesterol is associated with SCD. The eye disease progresses with age, independent of blood cholesterol value. From the beginning, even though a clinician, I continued recruitment of affected individuals in my hope that understanding this rare eye disease, could lead to better understanding of systemic cholesterol and lipid metabolism. One early collaborator, Howard Kruth MD, shared my vision. Later on, Mike Nickerson Ph.D. also agreed with the importance of finding the gene for this rare disease. I performed corneal transplantation surgery on patients visually disabled from the corneal clouding of SCD and sent the tissue to Dr. Kruth?s laboratory for analysis which revealed that the abnormal lipid deposition was entirely HDL, not LDL suggesting a local abnormality of HDL metabolism. At the same time we found that the disease mapped to chromosome 1, but it took another decade before we and another group independently identified mutations in SCD patients in the UBIAD1 gene on chromosome 1p36. Recruitment efforts continued internationally. By 2007, I had followed 115 individuals who had SCD for up to 18 years. Although the disease had been thought to be visually benign, 54% of patients 50 and younger and 77% of patients 70 and younger had reported corneal transplant surgery. Many patients without corneal crystals eluded correct diagnosis because of the confusing nomenclature. For this reason, I founded the International Committee for Classification of Corneal Dystrophies (IC3D) which revised the entire corneal dystrophy nomenclature and also renamed this disease Schnyder corneal dystrophy. Most recently UBIAD1 has been found by others to be a human vitamin K2 (MK-4) biosynthetic enzyme and has been found to have links to bladder cancer and Parkinson?s disease.
Biography
Jayne S. Weiss is Chair of the LSU Department of Ophthalmology, Herbert E Kaufman MD endowed Chair, Professor of Ophthalmology, Pharmacology and Pathology and Director of LSU Eye Center in New Orleans, Louisiana. She began her research on Schnyder corneal dystrophy 25 years ago recruiting patients internationally leading to the gene discovery. The misleading disease nomenclature led her to establish the International Committee for Classification of Corneal Dystrophies whose new nomenclature system including genetic information is now used for the dystrophies. She is a member of the National Advisory Eye Council, a consultant to the FDA Ophthalmic Devices Panel and Assistant Editor of the journal, Cornea.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7